Delivery Order 36F79722D0165-36C24526N0689

<p>Veterans Integrated Service Network 5 issued a $3,998.50 delivery order to Ardelyx, Inc. on June 12, 2026, for XPHOZAH 20 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with an ultimate completion date of June 16, 2026. Place of performance is Dublin, OH. No set-aside was used.</p>

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a delivery order to Ardelyx, Inc. on June 26, 2026, for XPHOZAH 30 mg with a ceiling value of $1,991.36, with ultimate completion on June 30, 2026.</p> <p>The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Dublin, OH 43017. Pricing is firm fixed price, and no socioeconomic set-aside was applied.</p>

Veterans Integrated Service Network 5 issued a $2,016.52 delivery order to Ardelyx, Inc. on December 31, 2025, for XPHOZAH 30 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside designation. Place of performance is Dublin, OH. The ultimate completion date is January 2, 2026. The Federal Supply Schedule provides the parent vehicle framework for VA medical centers nationwide to procure specialized medications for veterans with...

Ardelyx, Inc., a pharmaceutical company based in Fremont, California, was awarded a delivery order for XPHOZAH 30 mg by Veterans Integrated Service Network 5 (VISN 5), a component of the Department of Veterans Affairs. This contract, valued at $2,016.52, represents a firm fixed-price delivery order issued on September 19, 2025, with an ultimate completion date of September 23, 2025. The award is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and will be...

<p>Veterans Integrated Service Network 4 issued a purchase order to Cardinal Health 414, LLC on April 12, 2025, for Xofigo radiopharmaceutical with a ceiling value of $23,971.71. Performance takes place in Philadelphia, Pennsylvania. The order is firm fixed price with no set-aside designation and an ultimate completion date of April 11, 2026.</p>

Veterans Integrated Service Network 5 issued a delivery order to Travere Therapeutics, Inc. on June 24, 2026, for Filspari 400 mg with a ceiling value of $15,866.58, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside. Place of performance is Monroeville, PA. Ultimate completion date is June 26, 2026. The FSS-61-IB is a multiple-award federal supply schedule for pharmaceutical products under which the VA issues delivery...

<p>Veterans Integrated Service Network 5 issued a delivery order to UCB Pharma, Inc. on June 18, 2026, for Zilbrysq 32.4 MG with a ceiling value of $31,040.96 under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside.</p> <p>Place of performance is Pittsburgh, PA 15205. The ultimate completion date is June 22, 2026.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 25, 2026, with a ceiling value of $4,241.06 for supply of Xifaxan 550 mg tablets (60-count). Place of performance is Conshohocken, PA. The order ultimate completion date is February 26, 2026. This is a firm fixed-price delivery order issued under no set-aside. The parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, serves as the...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for XIFAXAN 550 MG Tablet 60s with a ceiling value of $5,857.18.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 24, 2026. This is a firm fixed-price delivery order with no set-aside applied.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a $10,303.55 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 15mg/45mg medication for patient E.W. The award was issued on March 26, 2021, with an ultimate completion date of April 2, 2021. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Richmond,...